论文部分内容阅读
我院参加了国家1035工程项目——“茶色素”科研协作三期临床试验项目。在临床上使用茶色素胶囊治疗高脂蛋白血症100例,取得了较好的效果,现报告如下。对象和方法一、病例选择:诊断标准:血脂(TC.TG.HDL-CLDL-C或其中任何一项)异常者100例。除外6个月内心肌梗塞、高血压Ⅲ期、妊娠及严重肝、肾疾患,精神病患者。年龄36~75岁(平均54.86)。男62例,女36例,少数民族(维、哈、蒙)53例,汉族47例。其中TC异常者98例,TG异常87例,HDL-C异常53岁,LDL-C异常84例。我院血脂正常值:TC2.33~5.69mmol/L,TG0.565~1.695mmol/L,HDL—C1.03~1.55mmol/L,LDL-C≤3.36mmol/L。该
Our hospital participated in the national 1035 project - “tea pigment” research collaboration phase III clinical trial project. In the clinical use of tea pigment capsules in the treatment of hyperlipoproteinemia in 100 cases, and achieved good results, are as follows. Subjects and methods A case selection: diagnostic criteria: blood lipids (TC.TG.HDL-CLDL-C or any one of them) were abnormal in 100 cases. Except 6 months myocardial infarction, high blood pressure Ⅲ, pregnancy and severe liver and kidney disease, mental illness. Age 36 to 75 years (average 54.86). 62 males and 36 females, 53 minorities (Victoria, Kazakhstan, Mongolia), 47 Han patients. There were 98 cases of abnormal TC, 87 cases of abnormal TG, abnormal HDL-C 53 years old, 84 cases of LDL-C abnormalities. Our normal blood lipids: TC2.33 ~ 5.69mmol / L, TG0.565 ~ 1.695mmol / L, HDL-C1.03 ~ 1.55mmol / L, LDL-C≤3.36mmol / L. This